The theme for ACannabis 2024 was Innovate, Collaborate Grow. Dive back in to any session with our video library.
Session List – Day 1
- Session 1 – Welcome and Opening
- Australian Medicinal Cannabis Market Landscape Past, Present and Future: What are the Trends
- Session 2 – Presentations and Panel Discussion: Market Data / Products available in Australia
- Session 3 – Presentation and Panel Discussion: Patients / Production Pathways
- Australian Regulatory & Legislative Landscape
- Session 4 – In Conversation with the Australian Regulators
- Session 4a – TGA update
- Session 5 – AHPRA’s Role in Regulating Health Practitioners
- Session 6 – Legalisation: What is the Current State of Medicinal Cannabis Legislation
- Session 7 – Community Attitudes Toward Legislation
- Session 8 – Where are we today in Australia: CEO Roundtable
- Olivia Newton-John Service to Industry Award
Session List – Day 2
- Session 9 – Welcome Day 2
- Session 10 – Global Cannabis Markets – Trends and Opportunities
- Session 11 – Exporters Roundtable
- Session 12 – New Horizons: Putting the Australian Medicinal Cannabis Industry on the Global Stage
- Session 13 – Ambition Into Action – Building Competitive Value Chains
- Patients at the Centre
- Session 14 – Plant to Pre-Clinical Research: Overview of Pre-Clinical Trials
- Session 15 – Clinical Research: Overview of Medicinal Cannabis Clinical Trials
- Session 16 – Prescribing for special patient populations
- Session 17 – Patient Journey
Speaker Presentations – Day 1
Session 1 – Opening & Welcome
Peter Koetsier, Chair, MCIA
The Hon Ged Kearney MP, Assistant Minister for Health and Aged Care
Australian Medicinal Cannabis Market Landscape Past, Present and Future: What are the Trends
Session 2 – Presentations and Panel Discussion
A deep dive into:
- Market Data including TGA, TGA FOI and NostraData
- Products available in Australia
Moderator:
- Cassandra Hunt, Industry Advisor
Speakers:
- Rhys Cohen, Policy Officer, Penington Institute
- Tom Brown, Co-founder, Honahlee
- Sharon Miller, Proprietor/Consultant Pharmacist, MediGreen Dispensary and Clinic
Session 2 Downloads (PDF)
Deep Dive in to Market Data and Products available in Australia – Rhys Cohen
The Australian Medicinal Cannabis Market Trends – Tom Brown
Session 3 – Presentation and Panel Discussion
A deep dive into:
- Patients – patient profiles and indications being prescribed
- Production Pathways – from origin to patients
Moderator:
- Clare Barker, Industry Expert
Panelists:
- Barry Cox, General Manager, Steritech
- Phoebe Macleod, Managing Director, Heyday Medical
- Rhys Staley, Vice President, Montu
Session 3 Download (PDF)
Patients and Production Pathways – Phoebe Macleod
Australian Regulatory & Legislative Landscape
Session 4 – In Conversation with the Australian Regulators
Discussions and updates on ODC and TGA activity in the medicinal cannabis space
Followed by Q & A
Moderator:
- Clare Barker, Industry Expert
Presenters:
- Chris Bedford, First Assistant Secretary, Regulatory Practice and Support Division, HPRG
- Avi Rebera, Assistant Secretary, Office of Drug Control
- Prof Robyn Langham, Chief Medical Advisor, TGA
Session 4 Download (PDF)
Discussions and updates on TGA activity in the medicinal cannabis space
Session 4a – TGA update: GMP and Advertising
Followed by Q & A
Presenters:
- Hien Le, Director, Advertising and Product Investigation Section, Regulatory Compliance Branch, TGA
- Dr Katherine Clark, Director GMP Operations and Strategy Section, Manufacturing Quality Branch, TGA
Session 4a Download (PDF)
TGA update: GMP and Advertising – Hien Le and Dr Katherine Clark
Session 5 – AHPRA’s Role in Regulating Health Practitioners
Followed by Q & A
Moderator:
- Fiona Patten MP, Former Member of Parliament
Presenter:
- Rachel Griffiths, Manager, Strategic Policy Australian Health Practitioner Regulation Agency
- Tom Hall, National Manager, Notifications – Strategy and Planning, Australian Health Practitioner Regulation Agency
Session 6 – Legalisation: What is the Current State of Medicinal Cannabis Legislation
Fireside Chat
Moderator:
- Fiona Patten MP, Former Member of Parliament
Speaker:
- David Ettershank MP, Member for Western Metropolitan Region, Legalise Cannabis Victoria
Session 7 – Community Attitudes Toward Legislation
Moderator:
- Fiona Patten MP, Former Member of Parliament
Presenter:
- John Ryan, CEO, Penington Institute
Session 7 Download (PDF)
Community Attitudes Toward Legislation – John Ryan
Session 8 – Where are we today in Australia: CEO Roundtable
Panel Discussion with Industry Leaders
Moderator:
- Shane Duncan, Industry Expert
Speakers:
- Ean Alexander, CEO & Director, Altum
- Tommy Huppert, CEO, Cannatrek
- Rhys Staley, Vice President, Montu
- Kristin Viccars, Managing Director, MedReleaf Australia
Olivia Newton-John Service to Industry Award
Recognising excellence in the medicinal cannabis industry
Presented by:
- Peter Crock, Director, MCIA
Speaker Presentations – Day 2
Session 9 – Welcome
Peter Koetsier, Chair, MCIA
Councillor Dr Olivia Ball, Portfolio Lead for Health, Wellbeing and Belonging, City of Melbourne
International Medicinal Cannabis Market Landscape
Session 10 – Global Cannabis Markets – Trends and Opportunities
- Key markets in terms of sales and regulatory developments
Moderators:
- Rosemary Richards, Director, Bowman Richards & Associates
- Cam Scadding, Founder and Managing Director, SourceCertain
Keynote Presentation
- Deepak Anand, Principal, ASDA Consultancy Services
Session 10 Download (PDF)
Global Cannabis Update – Deepak Anand
Session 11 – Exporters Roundtable
Hot Topic:
- Israel’s anti-dumping investigation (Canada)
Panelists:
- Deepak Anand, Principal, ASDA Consultancy Services
- Andrew Dowling, Lawyer & Co-Founder, AltMed
- James Gaskell, Chief Operating Office, The Australian Natural Therapeutics Group
- Paul Long, CEO, Little Green Pharma
- Nan-Maree Schoerie, Managing Director, ECS Botanics
Session 12 – New Horizons: Putting the Australian Medicinal Cannabis Industry on the Global Stage
Presentation and Panel Discussion
- Australian medicinal cannabis industry strategic export roadmap
- Navigating export markets and where Australia should focus
Presenter:
- Rosemary Richards, Director, Bowman Richards & Associates
Panelists:
- Deepak Anand, Principal, ASDA Consultancy Services
- Barry Cox, General Manager, Steritech
- Dirk Beelen, CCO, MedTEC Pharma
Session 13 – Ambition Into Action – Building Competitive Value Chains
Presentation and Panel Discussion
Presenter:
- Cam Scadding, Founder and Managing Director, SourceCertain
Panelists:
- Dirk Beelen, CCO, MedTEC Pharma
- Andres Fajardo, CEO & Director, CleverLeaves
- Kyle Hunt, CEO, Health Care Providers Association
Session 13 Download (PDF)
Ambition Into Action – Cameron Scadding
Patients at the Centre
Session 14 – Plant to Pre-Clinical Research: Overview of Pre-Clinical Trials
Moderator:
- Peter Crock, Director, MCIA
Fireside Chat:
- Prof Tony Bacic, Director ARC MedAg Hub
- Dr Filippa Brugliera, Chief Scientist, Cann Group
- Prof Iain McGregor, Psychopharmacology and Academic Director, The Lambert initiative, University of Sydney
Research Presentations:
- Professor Ross Bathgate, Leader Neurotherapeutics Theme, The Florey Institute of Neuroscience and Mental Health
- Associate Professor Monika Doblin, Research Director, ARC Research Hub For Medicinal Agriculture
- Danielle McCartney, Postdoctoral Research Associate, Lambert Initiative, University of Sydney
- Chase (Chaseley) McKenzie, PhD student, University of Melbourne and The Florey Institute
- Ben Wee, PhD student, MedAg Hub LTU
- Rupinder Brar, Founder & Director, Greenlab
Session 14 Research Presnetation Downloads (PDF)
The most common targets of Cannabinoids – Professor Ross Bathgate
Mitigation of Hop Latent Viroid (HLVd) in Australia using biotechnology tools – Associate Professor Monika Doblin
Does CBD Enhance Exercise Enjoyment? – Danielle McCartney
Cannabinoids and HCN1-epilepsy – Chase (Chaseley) McKenzie
Medical Cannabis New Zealand Updates – Rupinder Brar
Session 15 – Clinical Research: Overview of Medicinal Cannabis Clinical Trials
Presenter:
- Mary Nteris, Director, Enimera RegsPlus
Session 15 Download (PDF)
Clinical Research: Overview of Medicinal Cannabis Clinical Trials – Mary Nteris
Session 16 – Prescribing for special patient populations
Moderator:
- Martin Lane, Co-founder, Cannabiz
Panelists:
- Dr Dev Banerjee, Sleep & Cannabinoid Physician
- Kyle Hunt, CEO, Health Care Providers Association
- Lisa Todd, Clinical Governance and Policy Manager, Epilepsy Action Australia
- David Lott, Vivace Health
- Dr Michael Mumford, Provocatus
Session 17 – Patient Journey
In Conversation with:
- Mark Brayshaw, Managing Director, Levin Health
- Alastair Clarkson, AFL Coach & former AFL Player
- Damien Oliver, Australia’s Greatest Jockey of All Time